Clinical Trials · NCT00386984
Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- University Hospital Freiburg
- Enrollment
- 108
- Start date
- Oct 1999
- Locations
- 1 site, Germany
- Primary endpoint
- Overall survival time